Dyadic International, Inc. announced that they have strengthened their European leadership team with the addition of two senior level positions. Dr. Ronen Tchelet has joined the Company's European leadership team as the Vice President of Business Development. He joins Dyadic from Codexis, where he served as Vice President and Managing Director of their Research and Development laboratories in Hungary.

Prior to Codexis, Dr. Tchelet served as Chief Technology Officer of Biotechnology for the API division of Teva Pharmaceuticals. In this new position, Ronen will play a key role in driving business development efforts across all markets, as well as, Dyadic's internal and third party research and development projects. The company also announced that next month Andre Klaassen will be joining Dyadic's European sales team as the new Director of Sales for Europe.

Andre has spent the past two decades in enzyme sales at DuPont and Genencor in a variety of senior roles. He began his career in engineering and operational roles at Gist-Brocades, now part of DSM. As Director of Sales, Andre will manage the day-to-day European sales operations and help support new product development in Dutch research facility.

In addition, Andre will provide key account management, and assume global responsibility for starch and alcohol enzyme business. Both Dr. Tchelet and Mr. Klaassen will be based out of research center in Wageningen, Netherlands.